Ai zheng = Aizheng = Chinese journal of cancer · 2005
[Experimental research on effects of different T cell ratios of graft to receptor on severity of GVHD after allo-stem cell transplantation].
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Xiao-Dong, Weng Xia, Deng Xiao-Hui, Liang Hui
Аннотация
BACKGROUND & OBJECTIVE: Allogeneic stem cell transplantation has achieved great progress in hematology, and provided possibility to cure malignant hematological diseases. Graft-versus-host disease (GVHD) is a significant complication after transplantation with a mortality of over 30%. In clinical practice we noticed that the successful implantation and the severity of GVHD were associated with T cell ratio of graft to receptor after pretreatment. This study was to set up rat allo-stem cell transplantation model, and explore effects of different T cell ratios of graft to receptor on severity of GVHD.
METHODS: SD rats were selected as receptor, and pretreated with total body irradiation (TBI), and cyclophosphamide (CTX). WISTAR rats were used as donors, their bone marrow cells were collected as graft. Receptors were transfused with different ratios of T cells (1:1, 2:1, and 4:1). Life-span, clinical and pathologic GVHD scores were observed.
RESULTS: When T cell ratios of graft to receptor were 1:1, 2:1, and 4:1, life-spans of receptors were (16.7+/-1.3) d, (16.8+/-1.5) d, and (15.0+/-1.7) d, respectively; clinical GVHD scores of receptors were 2.4+/-0.6, 3.3+/-1.2, and 5.3+/-1.4, respectively. Life-span, and clinical and pathologic GVHD scores of receptors transfused with T cells of 1:1 and 2:1 were significantly different from those of receptors transfused with T cells of 4:1(P<0.05).
CONCLUSION: When T cell ratio of graft to receptor was 1:1, or 2:1, the GVHD was comparatively mild; when this ratio reached to 4:1, the GVHD was aggravated.
METHODS: SD rats were selected as receptor, and pretreated with total body irradiation (TBI), and cyclophosphamide (CTX). WISTAR rats were used as donors, their bone marrow cells were collected as graft. Receptors were transfused with different ratios of T cells (1:1, 2:1, and 4:1). Life-span, clinical and pathologic GVHD scores were observed.
RESULTS: When T cell ratios of graft to receptor were 1:1, 2:1, and 4:1, life-spans of receptors were (16.7+/-1.3) d, (16.8+/-1.5) d, and (15.0+/-1.7) d, respectively; clinical GVHD scores of receptors were 2.4+/-0.6, 3.3+/-1.2, and 5.3+/-1.4, respectively. Life-span, and clinical and pathologic GVHD scores of receptors transfused with T cells of 1:1 and 2:1 were significantly different from those of receptors transfused with T cells of 4:1(P<0.05).
CONCLUSION: When T cell ratio of graft to receptor was 1:1, or 2:1, the GVHD was comparatively mild; when this ratio reached to 4:1, the GVHD was aggravated.